Suppression of STK11 induces expansion of polymorphonuclear myeloid-derived suppressive cells and activation of immune signaling in breast cancer
Abstract The tumor microenvironment in breast cancer is typically immunosuppressive. Combined neoadjuvant chemotherapy and immunotherapy is the standard of care for high-risk, triple-negative breast cancer patients, but it is not routinely applied to other breast cancer subtypes. Somatic mutation of...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer
2025-10-01
|
| シリーズ: | Cancer Immunology, Immunotherapy |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1007/s00262-025-04189-8 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|